Valeant Pharmaceuticals International, Inc., (NYSE: VRX) (TSX: VRX) completed its acquisition of Solta Medical on January 23, 2014. Solta Medical will retain its name and its product offering will be integrated into Valeant’s aesthetics portfolio. For Investor Relations information on Valeant, click here.
At Solta, we have often been labeled as a “medical device” company. But we prefer to think of Solta in different terms. We are dynamic, global business leaders defining an evolving and expanding industry. We are an innovation-driven design studio that engineers breakthrough technologies and stunning designs with intuitive user interfaces. We are a powerful house of brands with the marketing savvy to connect with physicians and consumers around the world.And, we are a powerful house of brands with the marketing savvy to connect with physicians and consumers around the world. Our brands deliver real solutions for patients’ aesthetic needs – as well as real business growth for our partner physicians and retailers.